SEATTLE, Wash.--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the appointment of Dale R. Levitzke as Vice President of Global Sales, Life Sciences. Mr. Levitzke will be responsible for expanding global sales for NanoString’s research products business and associated nCounter® Analysis System, an advanced multi-application technology platform based on digital molecular barcoding.
Mr. Levitzke joins NanoString from Illumina, Inc. (NASDAQ:ILMN) where he was Senior Director and Global Sales Manager for the company's PCR division, created following Illumina's acquisition of Helixis in 2010. In that role, he led all aspects of global sales for Illumina's quantitative real-time PCR product line and established a global distribution network with 38 distributors covering 126 countries. Previously, he headed global sales for Helixis, Inc., a developer of advanced nucleic acid analysis tools for research and applied applications. Mr. Levitzke also held the position of General Manager of Corbett Robotics Inc., establishing the direct sales, administrative and service office for Corbett Life Sciences in the United States. Mr. Levitzke began his career as a research scientist and served as a Core Facility Manager at the University of Newcastle’s Analytical and Biomolecular Research Facility. Mr. Levitzke earned a Bachelor of Science with honors degree in molecular biology at La Trobe University Melbourne.
Mr. Levitzke commented: “While real-time PCR revolutionized the field of nucleic acid analysis more than 15 years ago, advances in genomics have now unlocked the ability for researchers to move from studying single genes to networks of genes in complex pathways. This requires a new set of tools, and NanoString’s nCounter Analysis System is uniquely suited for researchers interested in studying hundreds of genes and other biological targets such as miRNAs and DNA copy number variations with digital precision. I am very excited to be part of a new revolution in biology powered by NanoString’s tools.”
“Dale brings a wealth of experience and an impressive track record in global sales growth and channel development,” said Barney Saunders, Senior Vice President and General Manager, Life Sciences for NanoString Technologies. “His global commercial experience will be important as we continue to expand our commercial footprint outside the United States and increase our customer base for the nCounter system and assay kits.”
The nCounter Analysis System is a fully automated, multi-application digital detection and counting system with a very simple workflow. The assay kits contain all of the reagents and consumables needed to conduct an experiment. Minimal sample input requirements and compatibility with a variety of sample types, including FFPE, make it a particularly attractive solution for cancer research. NanoString provides assays for copy number variation, gene expression and miRNA analysis.
Additional information is available at www.nanostring.com.
About NanoString Technologies, Inc.
NanoString Technologies is a privately held provider of life science tools for translational research and developer of molecular diagnostics. The company’s nCounter Analysis System is the first and only technology platform to deliver highly multiplexed, direct profiling of individual molecules in a single reaction without amplification. The nCounter Analysis System offers a cost-effective way to easily profile hundreds of gene transcripts, copy number variations, or miRNAs simultaneously with high sensitivity and precision. The company’s technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. NanoString is also developing the technology for use in molecular diagnostics.
The NanoString Technologies logo, NanoString, NanoString Technologies and nCounter are registered trademarks of NanoString Technologies, Inc. All other trademarks are property of their respective owners.